The presence of miR-186-5p has been linked to drug resistance in treatments such as cisplatin, methotrexate, and taxol by targeting twist-related protein-1 (TWIST-1), a major EMT-related transcription factor in breast cancer [84] and gastric cancer [85,86]. The gene discussed is TWIST1; the disease is gastric cancer.